Research Report Identifies Prothena, UROGEN PHARMA, Mizuho Financial Group, 1-800 FLOWERS.COM, Willis Towers Watson Public, and First Connecticut with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Prothena Corporation PLC (NASDAQ:PRTA), UROGEN PHARMA (NASDAQ:URGN), Mizuho Financial Group, Inc. (NYSE:MFG), 1-800 FLOWERS.COM, Inc. (NASDAQ:FLWS), Willis Towers Watson Public Limited Company (NASDAQ:WLTW), and First Connecticut Bancorp, Inc. (NASDAQ:FBNK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PRTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=PRTA
URGN DOWNLOAD: http://Fundamental-Markets.com/register/?so=URGN
MFG DOWNLOAD: http://Fundamental-Markets.com/register/?so=MFG
FLWS DOWNLOAD: http://Fundamental-Markets.com/register/?so=FLWS
WLTW DOWNLOAD: http://Fundamental-Markets.com/register/?so=WLTW
FBNK DOWNLOAD: http://Fundamental-Markets.com/register/?so=FBNK

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Prothena Corporation PLC (NASDAQ:PRTA), UROGEN PHARMA (NASDAQ:URGN), Mizuho Financial Group, Inc. (NYSE:MFG), 1-800 FLOWERS.COM, Inc. (NASDAQ:FLWS), Willis Towers Watson Public Limited Company (NASDAQ:WLTW), and First Connecticut Bancorp, Inc. (NASDAQ:FBNK) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 13th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

PROTHENA CORPORATION PLC (PRTA) REPORT OVERVIEW

Prothena's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Prothena reported revenue of $0.23MM vs $0.17MM (up 33.92%) and basic earnings per share -$1.25 vs -$1.41. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Prothena reported revenue of $27.52MM vs $1.06MM (up 2,508.44%) and basic earnings per share -$4.07 vs -$4.66. Prothena is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.99. The estimated EPS forecast for the next fiscal year is -$4.59 and is expected to report on February 13th, 2019.

To read the full Prothena Corporation PLC (PRTA) report, download it here: http://Fundamental-Markets.com/register/?so=PRTA

-----------------------------------------

UROGEN PHARMA (URGN) REPORT OVERVIEW

UROGEN PHARMA's Recent Financial Performance

UROGEN PHARMA is expected to report earnings on March 15th, 2018. The report will be for the fiscal period ending December 31st, 2017. The estimated EPS forecast for the next fiscal year is -$2.46 and is expected to report on March 15th, 2018.

To read the full UROGEN PHARMA (URGN) report, download it here: http://Fundamental-Markets.com/register/?so=URGN

-----------------------------------------

MIZUHO FINANCIAL GROUP, INC. (MFG) REPORT OVERVIEW

Mizuho Financial Group's Recent Financial Performance

For the twelve months ended March 31st, 2017 vs March 31st, 2016, Mizuho Financial Group reported interest income of $13,443.66MM vs $11,837.92MM (up 13.56%) and basic earnings per share $0.44 vs $0.45 (down 1.61%). Mizuho Financial Group is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.07. The estimated EPS forecast for the next fiscal year is $0.42 and is expected to report on May 21st, 2018.

To read the full Mizuho Financial Group, Inc. (MFG) report, download it here: http://Fundamental-Markets.com/register/?so=MFG

-----------------------------------------

1-800 FLOWERS.COM, INC. (FLWS) REPORT OVERVIEW

1-800 FLOWERS.COM's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, 1-800 FLOWERS.COM reported revenue of $526.09MM vs $554.55MM (down 5.13%) and basic earnings per share $1.09 vs $0.97 (up 12.37%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, 1-800 FLOWERS.COM reported revenue of $1,193.63MM vs $1,173.02MM (up 1.76%) and basic earnings per share $0.68 vs $0.57 (up 19.30%). 1-800 FLOWERS.COM is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.17. The estimated EPS forecast for the next fiscal year is $0.54 and is expected to report on August 23rd, 2018.

To read the full 1-800 FLOWERS.COM, Inc. (FLWS) report, download it here: http://Fundamental-Markets.com/register/?so=FLWS

-----------------------------------------

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY (WLTW) REPORT OVERVIEW

Willis Towers Watson Public's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Willis Towers Watson Public reported revenue of $2,078.00MM vs $1,927.00MM (up 7.84%) and basic earnings per share $1.86 vs $1.02 (up 82.35%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Willis Towers Watson Public reported revenue of $8,202.00MM vs $7,887.00MM (up 3.99%) and basic earnings per share $4.21 vs $3.07 (up 37.13%). Willis Towers Watson Public is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $3.71. The estimated EPS forecast for the next fiscal year is $10.86 and is expected to report on February 14th, 2019.

To read the full Willis Towers Watson Public Limited Company (WLTW) report, download it here: http://Fundamental-Markets.com/register/?so=WLTW

-----------------------------------------

FIRST CONNECTICUT BANCORP, INC. (FBNK) REPORT OVERVIEW

First Connecticut's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, First Connecticut reported interest income of $25.55MM vs $22.16MM (up 15.30%) and basic earnings per share $0.03 vs $0.29 (down 89.66%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, First Connecticut reported interest income of $98.48MM vs $86.99MM (up 13.22%) and basic earnings per share $1.07 vs $1.02 (up 4.90%). First Connecticut is expected to report earnings on April 17th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $1.93 and is expected to report on January 23rd, 2019.

To read the full First Connecticut Bancorp, Inc. (FBNK) report, download it here: http://Fundamental-Markets.com/register/?so=FBNK

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.